---
document_datetime: 2023-09-21 17:44:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/optruma-epar-all-authorised-presentations_en.pdf
document_name: optruma-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9789283
conversion_datetime: 2025-12-19 22:09:27.287964
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA(EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging    | Pack size   |
|-----------------|-------------------|------------|-----------------------|---------------------------|------------------------|-------------|
| EU/1/98/074/001 | Optruma           | 60 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE) | 14 tablets  |
| EU/1/98/074/002 | Optruma           | 60 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE) | 28 tablets  |
| EU/1/98/074/003 | Optruma           | 60 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PE/PCTFE) | 84 tablets  |
| EU/1/98/074/004 | Optruma           | 60 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)          | 100 tablets |